Oligonucleotide sequence formula for labeling olignucleotide probes and proteins for in-situ analysis
AssigneeVentana Medical Systems, Inc.
InventorsJoseph G. Utermohlen, John F. Connaughton
Life of this patent
Estimating the term…
Loading patent…
AssigneeVentana Medical Systems, Inc.
InventorsJoseph G. Utermohlen, John F. Connaughton
Estimating the term…
The present invention provides oligonucleotide probes and oligonucleotide probe collections and protein labeling for detecting or localizing a plurality nucleic acid target genes or antigens within a cell or tissue sample. Specifically, the invention provides collections of oligonucleotide probes for use in in situ hybridization analyses in which each probe has a label-domain with the sequence formulas of (CTATTTT)nCT, (AAAATAG)n or (TTTTATC)n or (GATAAAA)n in which all cases “n” would equal 1 or greater. The present invention provides collections or “cocktails” of oligonucleotide probes for detecting or localizing specific nucleic acid target genes within a cell or tissue sample. The cocktails are useful for detecting the following: the Kappa gene (SEQ ID NOS: 1-16 inclusive); the Lambda gene (SEQ ID NOS: 17 through 29 inclusive); the CMV (cytomegalovirus) gene (SEQ ID NOS: 30 through 50 inclusive); EBER (Epstein-Barr early RNA) gene (SEQ ID NOS: 51-54 inclusive); Alu (SEQ ID NOS: 55-56); PolyA (SEQ ID NO: 57); and the detection tail (SEQ ID NO: 58).
A method for preparing a synthetic oligonucleotide probe, comprising:
A synthetic oligonucleotide probe having a 5′ end and a 3′ end and comprising:
A synthetic oligonucleotide probe having a 5′ end and a 3′ end and comprising:
Dependencies are inferred from the claim text.